The Effect of Triglycyl-Lysine-Vasopressin (Terlipressin Inn, Glypressin^®) on Skin Blood Flow, Measured with Laser Doppler Flowmetry, Thermography and Plethysmography: A Dose-Response Study

References

• Altura B. M., Altura B. T. Actions of vasopressin oxytocin and synthetic analogs on vascular smooth muscle. Vasopressin and cardiovascular regulation. Fed Proc 1984; 43: 80–86
   PubMedGoogle Scholar
• Aronsen K. F., Wetterlin S., Emås S., Vojtisek V., Mulder J. L., Cort J. H. Die Wirkung von Triglycyl-Lysin-Vasopressin auf Kontrollpersonen und Patien-ten mit Blutungen des oberen Gastrointestinaltraktes. Klin Wochenschr 1975; 53: 747–753
   PubMedGoogle Scholar
• Blei A. T., Groszmann R. J., Gusberg R., Conn H. O. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Dig Dis Sci 1980; 25: 688–694
   PubMedGoogle Scholar
• Braverman I. M., Ken-Yen A. Ultrastructure of the human dermal microcirculation. III. The vessels in the mid- and lower dermis and subcutaneous fat. J Invest Dermatol 1981; 77: 297–304
   PubMed Web of Science ®Google Scholar
• Clarke A. M., Salomon J. R., Keogh E. J. Use of a new vasoconstrictor in the management of burns. Med J Aust 1972; 2: 361–362
   PubMedGoogle Scholar
• Cope O., Langohr J. L., Moore F. D., Webster R. C. Expeditious care of full thickness burn wounds by surgical excision and grafting. Ann Surg 1947; 125: 1–22
   Google Scholar
• Cort J. H., Albrecht I., Novakova J., Mulder J. L., Jost K. Regional and systemic haemodynamic effects of some vasopressins: Structural features of the hormone which prolong activity. Eur J Clin Invest 1975; 5: 165–175
   PubMed Web of Science ®Google Scholar
• Duner H., Kövamees A., Malmström G., Pernow B. Effect of ornithine-8-vasopressin on hemodynamics and diuresis in man. Acta Chir Scand 1971; 137: 201–207
   PubMedGoogle Scholar
• Eriksson B. F. Hemodynamic effects of vasopressin: An experimental study in normovolemic and hypovolemic anaesthetized dogs. Acta Chir Scand 1971; 414: 1
   Google Scholar
• Forsling M. L., Azez A. L., Miller M., Davies R., Donovan B. Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol 1980; 85: 237–244
   PubMed Web of Science ®Google Scholar
• Freeman JG. The haemodynamic responses to Glypressin. The British Society of Gastroenterology. Abstract Form, Spring Meeting, Brighton March, 1985
   Google Scholar
• Greenstein R. J., Dreiling D. A. Selective gastrointestinal circulatory changes due to a vasopressin hormonogen in the cat. Mt Sinai J Med (NY) 1983; 50: 498–500
   PubMedGoogle Scholar
• Greenstein R. J., Dreiling D. A. Feline genitourinary and systemic circulatory changes due to a vasopressin hormonogen. Mt Sinai J Med (NY) 1984; 51: 268–270
   PubMedGoogle Scholar
• Harmanci M. C., Kachadorian W. A., Valtin H., Discala V. A. Antidiuretic hormone-induced intramembranous alterations in mammalian collecting ducts. Am J Physiol 1978; 235: 440–443
   PubMedGoogle Scholar
• Holloway GA, Jr, Watkins D. W. Laser Doppler measurements of cutaneous blood flow. J Invest Dermatol 1977; 69: 306–309
   PubMed Web of Science ®Google Scholar
• Jackson D., Topley E., Cason J. S., Lowbury EJL. Primary excision and grafting of large burns. Ann Surg 1960; 152: 167–189
   PubMed Web of Science ®Google Scholar
• Jouglard J. P., Echinard C., Carlin G., Manelli J. C., Pa-Layret D. Severity and prognosis after early excisions from one to twenty percent of the body surface area. Scand J Plast Reconstr Surg 1979; 13: 121–125
   PubMed Web of Science ®Google Scholar
• Jurkiewicz M. J. Consensus summary on excisional therapy. J Trauma 1979; 19(Supplement)933–934
   PubMedGoogle Scholar
• Kyncl J., Rudinger J. Excretion of antidiuretic activity in the urine of cats and rats after administration of the synthetic hormonogen, N-glycyl-glycyl-glycyl-8-ly-sine-vasopressin (triglycyl-vasopressin). J Endocrinol 1970; 48: 157–165
   PubMedGoogle Scholar
• Liard J. F. Vasopressin in cardiovascular control: Role of circulating vasopressin. Clin Sci 1984; 67: 473–481
   PubMed Web of Science ®Google Scholar
• Ludatscher R. M. Ultrastructure of human dermal blood vessels with special reference to the endothelial filaments. Virchows Arch B Cell Path 1978; 27: 347–357
   PubMedGoogle Scholar
• MacMillan B. G. Early excision. Sixth National Burn Seminar. J Trauma 1967; 7: 75–79
   PubMedGoogle Scholar
• Morel F., Mylle M., Gottschalk C. W. Tracer microinjection studies of effect of ADH on renal tubular diffusion of water. Am J Physiol 1965; 209: 179–187
   PubMedGoogle Scholar
• Mouly R., Negre C. V. Utilisation dˆun vasoconstric-teur périphérique: l'ornithine-8-vasopressine (POR 8) en chirurgie plastique et esthétique. Ann Chir Plast Esthft 1983; 28: 390–392
   PubMedGoogle Scholar
• Nadvornikova H., Schück O. The influence of a single dose of vasopressin analogs on human renal potassium excretion. Int J Clin Pharmacol Ther Toxicol 1982; 20: 155–158
   PubMedGoogle Scholar
• Nakano J. Cardiovascular responses to neurohypophysial hormones. Handbook of physiology, Section 7, Endocrinology, Vol 4, Part I. Am Physiol Soc;, Bethesda 1974; 395–442
   Google Scholar
• Olesen B. W. Thermal comfort. Technical Review. Bryel and Kjaer, Denmark 1982
   Google Scholar
• Rabøl A., Juhl E., Schmidt A., Winkler K. The effect of vasopressin and triglycyl lysine vasopressin (Glypres-sin®) on the splanchnic circulation in cirrhotic patients with portal hypertension. Digestion 1976; 14: 285–289
   PubMed Web of Science ®Google Scholar
• Reid I. A., Schwartz J. Role of vasopressin in the control of blood pressure. Frontiers in neuroendocrin-ology, L. Martini, W. F. Ganong. Raven Press, New York 1984; 8: 177–197
   Google Scholar
• Sjöquist POB, Bjellin L., Carter A-M. Effect of a vasopressin analogue (N-glycyl-glycyl-glycyl-8-ly-sine-vasopressin) on organ blood flow in the pregnant guinea pig. Acta Pharmacol Toxicol 1977; 40: 369–377
   PubMedGoogle Scholar
• Tenland T., Salerud E. G., Nilsson G. E., Öberg PÅ. Spatial and temporal variations in human skin blood flow. Int J Microcirc Clin Exp 1983; 2: 81–90
   PubMedGoogle Scholar
• Vemersson E., Ahlgren I., Aronsen K. F., Palmer B. Lysine-vasopressin in excisional treatment of burns in pigs. Decreased blood loss and earlier circulatory recovery. Acta Chir Scand 1983; 149: 15–22
   PubMedGoogle Scholar
• Vemersson E., Ahlgren I., Aronsen K. F. Effects of lysine-vasopressin treatment on renal function in burned pigs. Scand J Plast Reconstr Surg 1983; 17: 25–31
   PubMedGoogle Scholar
• Vemersson E., Palmer B., Åberg M. Triglycyl-lysine-vasopressin or lysine-vasopressin in early excision of bums. An experimental study comparing the effects on blood loss hemodynamics and renal function. Scand J Plast Reconstr Surg 1984; 18: 285–290
   PubMedGoogle Scholar
• Vemersson E., Jacobsson S., Åberg M. Reduction of blood loss by triglycyl-lysine-vasopressin during early excision of bums in pigs. Scand J Plast Reconstr Surg 1984; 18: 291–296
   PubMedGoogle Scholar
• Vemersson E., Aronsen K. F., Åberg M. Circulatory and renal effects of triglycyl-lysine-vasopressin and excision in experimental bums. Eur Surg Res 1985; 17: 242–250
   PubMedGoogle Scholar
• Vosmik J., Jedlicka K., Mulder J. L., Cort J. H. Action of the triglycyl hormonogen of vasopressin (Glypressin-tGLVP) in patients with liver cirrhosis and bleeding esophageal varices. Gastroenterology 1977; 72: 605–609
   PubMed Web of Science ®Google Scholar
• Wambach G., Hummerich W., Konrads A., Dickmans A., Winkelmann W., Helber A. Einfluss von Triglycyl-Lysin-Vasopressin (Glycylpressin®) auf den systemi-schen arteriellen Blutdruck bei Patienten mit gastroin-testinaler Blutung. Therapiewoche 1981; 31: 6603–6609
   Google Scholar
• Wetterlin S. Hemodynamic changes in burned mice treated with triglycylvasopressin. Acta Chir Scand 1977; 143: 401–406
   PubMedGoogle Scholar
• Wetterlin S., Björkman I. Cardiac output and regional blood flow in untreated and triglycylvasopressin-treated burned mice. Scand J Plast Reconstr Surg 1977; 11: 109–113
   PubMed Web of Science ®Google Scholar